Davidson Kempner Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Davidson Kempner Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-650,536	Closed	-$112M	–	217
2015 Q1	$112M	Buy	+650,536	New	+$95.5M	2.38%	10
2014 Q4	–	Sell	-55,000	Closed	-$8.59M	–	193
2014 Q3	$8.59M	Buy	+55,000	New	+$7.97M	0.2%	102

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Davidson Kempner Capital Management's SLXP Position: Q2 2015 in Review

Davidson Kempner Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 650,536 shares — an estimated $112M sold.

Davidson Kempner Capital Management first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $112M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Davidson Kempner Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Davidson Kempner Capital Management sold 650,536 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $112M.
Davidson Kempner Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
Davidson Kempner Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $112M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.